# Octapharma Plasma Inc – FDA Inspection, Apr 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b989d6a1-86f2-4ac8-8208-1b54145c0574
Source feed: FDA_Inspections

> FDA inspection 1202927 of Octapharma Plasma Inc, April 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202927
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-04-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jennifer-l-sheehan/a49c628d-6eba-4b52-bafc-70785b9ba75e)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/1634ab19-cb2d-4656-a7bf-f6da12cc9d4d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d